Earnings Ahead

VRTX - Vertex Pharmaceuticals Incorporated

385.76 9.56 2.54

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

About

Profile

Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharma


Headquarters

Boston, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

VRTX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Vertex shares dip 2% as Q3 revenue, guidance falls shy of Street estimates
  • Vertex Pharmaceuticals Non-GAAP EPS of $4.08 beats by $0.11, revenue of $2.48B misses by $20M
  • Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
  • Biotechs rally with gene editing stocks among notable gainers
  • Vertex Pharmaceuticals Q3 2023 Earnings Preview
  • Goldman Sachs' 25 'conviction list' stocks to buy
  • Biggest stock movers today: AMD, WeWork, Paycom Software, CRISPR Therapeutics and more
  • CRISPR gains after FDA AdCom on gene editing therapy
  • CRISPR, Vertex gene editing therapy gets warm response from FDA panel
  • Gene editing stocks gain after Eli Lilly deal amid FDA AdCom
  • CRISPR on hold for trading amid key FDA meeting on gene editing drug
  • Pharma, PBMs spar over rising drug costs amid public scrutiny
  • FDA reviewers recommend more studies for Vertex sickle cell therapy: report
  • Editas upgraded at Citi ahead of FDA AdCom on gene editing therapy
  • Vertex Pharmaceuticals marketing chief disposes $2M worth stock
  • Vertex Pharmaceuticals executive chairman disposes stake worth $4.85M
  • Vertex updated data on diabetes candidate VX-880 encouraging
  • Vertex appoints Atkinson EVP Chief Technical Operations Officer
  • Bluebird bio favored at Baird as sickle cell disease space gets busy
  • Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
January 26, 2022 3.37 / 3.29 2.07B / 2B Beat!
November 2, 2021 3.56 / 3.09 1.98B / 1.86B Beat!
July 29, 2021 3.11 / 2.53 1.79B / 1.72B Beat!
April 29, 2021 2.98 / 2.7 1.72B / 1.66B Beat!
February 1, 2021 2.51 / 2.57 1.63B / 1.59B Beat!
October 29, 2020 2.64 / 2.35 1.54B / 1.49B Beat!
July 30, 2020 2.61 / 2.09 1.52B / 1.39B Beat!
April 29, 2020 2.56 / 1.87 1.52B / 1.3B Beat!
January 30, 2020 1.7 / 1.21 1.26B / 1.01B Beat!
October 30, 2019 1.23 / 1.15 949.83M / 950.95M
July 31, 2019 1.26 / 1.07 941.28M / 886.16M Beat!
April 30, 2019 1.14 / 1.01 858.29M / 851.35M Beat!
February 5, 2019 1.3 / 1.06 869.44M / 820.13M Beat!
October 24, 2018 1.09 / 1.02 783.86M / 790.69M
July 25, 2018 0.94 / 0.75 751.22M / 680.64M Beat!
April 26, 2018 0.76 / 0.63 638.88M / 622.11M Beat!
January 31, 2018 0.61 / 0.53 651.6M / 595.92M Beat!
October 25, 2017 0.53 / 0.31 578.2M / 520.1M Beat!
July 26, 2017 0.39 / 0.35 1.26B / 487.5M Beat!
April 27, 2017 0.41 / 0.37 714.7M / - Beat!
Date Price Open High Low Vol Change
Jan 29 441.52 437.74
442.92
430.81
1.0M 0.19%
Jan 28 440.68 443.88
446.98
438.01
1.2M -0.72%
Jan 27 443.88 436.72
447.72
435.33
1.6M 0.97%
Jan 24 439.62 438.73
442.66
436.61
1.6M -0.03%
Jan 23 439.73 429.25
442.89
424.54
1.7M 2.74%
 
Jan 22 428 427.89
432.6
424.65
1.2M 0.03%
Jan 21 427.89 427.94
430.53
423.49
1.6M 1.40%
Jan 17 422 422.73
428.25
419.27
1.8M 1.21%
Jan 16 416.96 423.41
424.58
415.15
1.2M -1.72%
Jan 15 424.26 415.13
425.49
415.13
1.7M 3.06%
Jan 14 411.66 411.94
414.5
408.02
1.4M -0.41%
Jan 13 413.37 408
416.55
397.24
1.9M 0.93%
Jan 10 409.56 406.17
413.52
405.17
1.7M -0.62%
Jan 8 412.11 410.71
412.36
407.24
1.2M 0.93%
Jan 7 408.32 402.99
410.81
401.54
1.7M 1.45%
Jan 6 402.49 401.31
404.74
399
2.2M -1.13%
Jan 3 407.11 407.57
411.65
406.4
1.1M 0.33%
Jan 2 405.76 403.14
409.6
402.72
1.3M 0.76%
Dec 31, 2024 402.7 399.63
404.99
399.63
1.0M 0.84%
Dec 30, 2024 399.35 404.54
407.35
399.06
1.5M -2.3%
Dec 27, 2024 408.76 405.26
410.98
404.49
1.4M -0.46%
Dec 26, 2024 410.65 407.2
411.29
406.02
1.2M 0.61%
Dec 24, 2024 408.18 401.53
410.68
401.27
1.5M 0.72%
Dec 23, 2024 405.27 391.87
405.93
390.92
2.2M 2.01%
Dec 20, 2024 397.27 395.72
401.31
386.49
6.2M 0.16%
Dec 19, 2024 396.64 391
404.04
377.85
8.2M -11.37%
Dec 18, 2024 447.5 467.06
471.05
445.87
1.8M -4.63%
Dec 17, 2024 469.24 468.07
474.18
465.62
1.3M 0.25%
Dec 16, 2024 468.09 463.37
470.08
462.13
1.5M 0.94%
Dec 13, 2024 463.73 462.33
466.71
459.79
1.1M -0.08%
Dec 12, 2024 464.12 466.52
470.25
460.05
959K -0.89%
Dec 11, 2024 468.29 472.31
472.33
460.74
1.0M -0.2%
Dec 10, 2024 469.22 473.3
476.46
465.12
865K -1%
Dec 9, 2024 473.98 467.33
476.02
467
1.3M 2.57%
Dec 6, 2024 462.1 458.06
465.9
456.86
1.1M 0.47%
Dec 5, 2024 459.92 461.35
467.06
457.96
1.2M -0.88%
Dec 4, 2024 463.98 454.72
464.87
450
1.2M 1.53%
Dec 3, 2024 456.97 462.86
468.51
455.01
1.2M -1.88%
Dec 2, 2024 465.73 467.48
468.19
463.05
960K -0.51%
Nov 29, 2024 468.13 463.6
470.93
462.33
771K 0.77%
Nov 27, 2024 464.56 464.81
470.42
462.01
1.0M -0.54%
Nov 26, 2024 467.07 464
467.96
459.07
1.3M 1.16%
Nov 25, 2024 461.71 456.58
462.95
455.83
2.2M 2.38%
Nov 22, 2024 450.97 454.3
457.54
449.04
1.3M 0.13%
Nov 21, 2024 450.37 454.24
455.43
445
1.5M -0.19%
Nov 20, 2024 451.23 448.46
451.76
445.38
1.7M 0.72%
Nov 19, 2024 448.01 462.8
463.9
447.14
2.2M -4.07%
Nov 18, 2024 467.01 465.19
468.88
458.05
1.1M 0.28%
Nov 15, 2024 465.7 478.56
479.93
458.1
2.6M -3.77%
Nov 14, 2024 483.96 495.62
496.33
483.55
1.2M -2.15%
Nov 13, 2024 494.61 491.34
498.25
491.03
1.1M 0.94%
Nov 12, 2024 490 503
508.04
489.02
1.4M -2.34%
Nov 11, 2024 501.72 518.27
518.35
500.13
1.3M -2.91%
Nov 8, 2024 516.74 507.17
519.88
504.94
1.3M 2.84%
Nov 7, 2024 502.45 493.7
504.31
486.64
992K 1.78%
Nov 6, 2024 493.64 505.35
506.65
485.29
1.6M -1.25%
Nov 5, 2024 499.88 483
503.2
474
1.7M 5.73%
Nov 4, 2024 472.8 473.91
475.48
468.77
1.2M 0.36%
Nov 1, 2024 471.12 471.06
475.73
463.14
1.4M -1.02%
Oct 31, 2024 475.98 471.58
477.7
468.98
1.4M 0%